Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

Alzheimer's disease (AD) staging criteria lack standardized, empirical description. Well‐defined AD staging criteria are an important consideration in protocol design, influencing a more standardized inclusion/exclusion criteria and defining what constitutes meaningful differentiation among the...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Ronald C., Graf, Ana, Brady, Chris, De Santi, Susan, Florian, Hana, Landen, Jaren, Pontecorvo, Mike, Randolph, Christopher, Sink, Kaycee M., Carrillo, Maria C., Weber, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655199/
https://www.ncbi.nlm.nih.gov/pubmed/38023620
http://dx.doi.org/10.1002/trc2.12434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655199/
https://www.ncbi.nlm.nih.gov/pubmed/38023620
http://dx.doi.org/10.1002/trc2.12434

Ejemplares similares